#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • High-grade B-cell lymphoma
    • Primary mediastinal large B-cell lymphoma
    • Diffuse large B-cell lymphoma
    Investigated drugs:
    • Tisagenlecleucel
    • Ibrutinib
    • Ifosfamide
    Austria France Germany Italy The Netherlands Norway +1

  • Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1
    Investigated drugs:
    • Golimumab
    • Guselkumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

    Not recruiting

    2 1 1
    Investigated drugs:
    • Gen1047
    Belgium Denmark France Italy The Netherlands Poland +1

  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study of Imetelstat in Patients with Low or Intermediate Risk Myelodysplastic Syndromes (MDS) Refractory to Erythropoiesis-Stimulating Agents

    Not recruiting

    4 1 1
    Investigated drugs:
    • Imetelstat Sodium
    Belgium Czechia France Germany Italy The Netherlands +2

  • Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated drugs:
    • Golimumab
    • Guselkumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer metastatic
    • HER2 positive breast cancer
    Investigated drugs:
    • Trastuzumab Emtansine
    • Trastuzumab Deruxtecan
    Belgium France Italy Spain

  • Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1
    Investigated diseases:
    • Bronchiectasis
    Investigated drugs:
    • Itepekimab
    Czechia Denmark France Germany Greece Italy +3

  • Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Preserved Ejection Fraction

    Not recruiting

    2 1
    Investigated diseases:
    • Heart failure with preserved ejection fraction
    Investigated drugs:
    • Tovinontrine
    Belgium Bulgaria Czechia Germany Hungary Italy +3

  • Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

    Not recruiting

    3 1 1
    Investigated drugs:
    • Tildrakizumab
    Czechia Estonia Germany Italy Poland Slovakia +1
Previous Page
1 … 50 51 52 53 54 … 65
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!